Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
about
Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.Emerging drugs for Waldenström's macroglobulinemia.Impact of disease on interferences in blood bioanalysis.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse modelsExcellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospital.Immunoglobulin M 'Flare' Seen in a Case of Waldenstrom's Macroglobulinemia: Successfully Managed by Therapeutic Plasma Exchange.Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection.Pathophysiology of Waldenström's macroglobulinemia.Waldenström's macroglobulinemia-associated renal amyloidosis presenting as a solitary lung mass.Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma.Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.
P2860
Q33395066-7F98F515-4C65-4B1A-8BF5-965FDB3F28A4Q33400780-595073CB-EB24-48FA-864B-40DB7652DF7FQ33408517-0A63C111-DDC0-41C6-86A2-F07982259A6BQ33421444-5E2F946C-86A2-4BEC-8376-CD807E299BFFQ33438490-533AE0B5-CAC3-49DD-8E8D-AC15EA011EBFQ37499211-CD860EE4-568F-42F2-ADB7-367627C23E4BQ37847176-6030E510-C4AB-4274-8A04-B60F38733117Q37943854-52D9F4C7-5571-4926-A2D3-EFC45FA408A0Q38150849-4260B06D-C461-42C9-A338-C25A7B428E1CQ40056963-0DCF7A39-6093-4735-A2F6-C47DC0D3A0B4Q41970906-0EF4CE38-C0D1-4AEE-9D9B-B4A22622DF4BQ41976266-9B5C7E49-E659-4CD9-AC84-1E31CD0C81B4Q42879189-5BAE3F0D-17FE-46FA-B443-721D537FD6A4Q43553373-AEE00EDA-9EA1-4EA5-9548-17A2F62ABB92Q45854126-529AD012-7224-4CFD-9DD6-F8E64D9D3C5CQ48172125-1785BCC4-94C4-4C94-90D9-323186D9E7EBQ51199274-E6979180-92C5-4696-BB26-62B3ED453429Q52840250-7DEB73D5-82F3-4B6D-876D-7CE4BBF8D487
P2860
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@en
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@nl
type
label
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@en
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@nl
prefLabel
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@en
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@nl
P356
P1476
Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
@en
P2093
Marvin J Stone
P356
10.3816/CLM.2009.N.026
P577
2009-03-01T00:00:00Z